These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 3958353

  • 21. Comparison of programmed electrical stimulation and ambulatory electrocardiographic (Holter) monitoring in the management of ventricular tachycardia and ventricular fibrillation.
    Platia EV, Reid PR.
    J Am Coll Cardiol; 1984 Sep; 4(3):493-500. PubMed ID: 6470328
    [Abstract] [Full Text] [Related]

  • 22. Predictors of efficacy of amiodarone and characteristics of recurrence of arrhythmia in patients with sustained ventricular tachycardia and coronary artery disease.
    Zhu J, Haines DE, Lerman BB, DiMarco JP.
    Circulation; 1987 Oct; 76(4):802-9. PubMed ID: 3652422
    [Abstract] [Full Text] [Related]

  • 23. Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrophysiologic study.
    Klein LS, Fineberg N, Heger JJ, Miles WM, Kammerling JM, Chang MS, Zipes DP, Prystowsky EN.
    Am J Cardiol; 1988 May 01; 61(13):1024-30. PubMed ID: 3364357
    [Abstract] [Full Text] [Related]

  • 24. Chronic effects of amiodarone in patients with refractory ventricular tachycardia.
    Saksena S, Rothbart ST, Cappello G.
    Int J Cardiol; 1983 Jun 01; 3(3):339-52. PubMed ID: 6347914
    [Abstract] [Full Text] [Related]

  • 25. Invasive and noninvasive methods to predict the long-term efficacy of amiodarone: a compilation of clinical observations using meta-analysis.
    Roberts SA, Viana MA, Nazari J, Bauman JL.
    Pacing Clin Electrophysiol; 1994 Oct 01; 17(10):1590-602. PubMed ID: 7800560
    [Abstract] [Full Text] [Related]

  • 26. Cardiac arrest and sudden death in patients treated with amiodarone for sustained ventricular tachycardia or ventricular fibrillation: risk stratification based on clinical variables.
    DiCarlo LA, Morady F, Sauve MJ, Malone P, Davis JC, Evans-Bell T, Winston SA, Scheinman MM.
    Am J Cardiol; 1985 Feb 01; 55(4):372-4. PubMed ID: 3969871
    [Abstract] [Full Text] [Related]

  • 27. Amiodarone in refractory life-threatening ventricular arrhythmias.
    Nademanee K, Singh BN, Hendrickson J, Intarachot V, Lopez B, Feld G, Cannom DS, Weiss JL.
    Ann Intern Med; 1983 May 01; 98(5 Pt 1):577-84. PubMed ID: 6846970
    [Abstract] [Full Text] [Related]

  • 28. Amiodarone therapy in symptomatic, sustained refractory atrial and ventricular tachyarrhythmias.
    Podrid PJ, Lown B.
    Am Heart J; 1981 Apr 01; 101(4):374-9. PubMed ID: 7211665
    [Abstract] [Full Text] [Related]

  • 29. The role of Holter monitoring in patients with recurrent sustained ventricular tachycardia: an electrophysiologic correlation.
    Ezri MD, Huang SK, Denes P.
    Am Heart J; 1984 Nov 01; 108(5):1229-36. PubMed ID: 6496281
    [Abstract] [Full Text] [Related]

  • 30. Long-term clinical outcome of ventricular tachycardia or fibrillation treated with amiodarone.
    McGovern B, Garan H, Malacoff RF, DiMarco JP, Grant G, Sellers TD, Ruskin JN.
    Am J Cardiol; 1984 Jun 01; 53(11):1558-63. PubMed ID: 6731300
    [Abstract] [Full Text] [Related]

  • 31. Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia.
    McKenna WJ, Oakley CM, Krikler DM, Goodwin JF.
    Br Heart J; 1985 Apr 01; 53(4):412-6. PubMed ID: 4039188
    [Abstract] [Full Text] [Related]

  • 32. A randomized clinical trial of the noninvasive and invasive approaches to drug therapy of ventricular tachycardia.
    Mitchell LB, Duff HJ, Manyari DE, Wyse DG.
    N Engl J Med; 1987 Dec 31; 317(27):1681-7. PubMed ID: 3320747
    [Abstract] [Full Text] [Related]

  • 33. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
    Castelli G, Ciaccheri M, Cecchi F, Troiani V, Nannini M, Marconi P, Olivotto J, Montereggi A, Dolara A.
    G Ital Cardiol; 1999 May 31; 29(5):514-23. PubMed ID: 10367218
    [Abstract] [Full Text] [Related]

  • 34. Disparity between the clinical and electrophysiologic effects of amiodarone in the treatment of recurrent ventricular tachyarrhythmias.
    Hamer AW, Finerman WB, Peter T, Mandel WJ.
    Am Heart J; 1981 Dec 31; 102(6 Pt 1):992-1000. PubMed ID: 7315716
    [Abstract] [Full Text] [Related]

  • 35. Ambulatory electrocardiographic correlates of ventricular inducibility during programmed electrical stimulation.
    Gradman AH, Batsford WP, Rieur EC, Leon L, Van Zetta AM.
    J Am Coll Cardiol; 1985 May 31; 5(5):1087-93. PubMed ID: 3989118
    [Abstract] [Full Text] [Related]

  • 36. Amiodarone: correlation of serum concentration with suppression of complex ventricular ectopic activity.
    Mostow ND, Rakita L, Vrobel TR, Noon DL, Blumer J.
    Am J Cardiol; 1984 Sep 01; 54(6):569-74. PubMed ID: 6475775
    [Abstract] [Full Text] [Related]

  • 37. Intravenous and oral loading versus oral loading alone with amiodarone for chronic refractory ventricular arrhythmias.
    Kerin NZ, Blevins RD, Frumin H, Faitel K, Rubenfire M.
    Am J Cardiol; 1985 Jan 01; 55(1):89-91. PubMed ID: 3966403
    [Abstract] [Full Text] [Related]

  • 38. [Prediction of long-term efficacy of amiodarone for refractory ventricular tachycardia: clinical significance of electrophysiologic study and Holter monitoring].
    Tsuchiya M, Kasanuki H, Ohnishi S, Hosoda S.
    J Cardiol; 1996 Nov 01; 28(5):267-76. PubMed ID: 8953400
    [Abstract] [Full Text] [Related]

  • 39. [Comparison between amiodarone and disopyramide in the treatment of ventricular extrasystoles].
    Gaudeau B, Badouraly A, Herpin D, Tournadre P, Boutaud P, Amiel A, Guillem JP, Demange J.
    Ann Cardiol Angeiol (Paris); 1986 Jan 01; 35(1):43-8. PubMed ID: 2421631
    [Abstract] [Full Text] [Related]

  • 40. Flecainide: electrophysiologic and antiarrhythmic properties in refractory ventricular tachycardia.
    Platia EV, Estes M, Heine DL, Griffith LS, Garan H, Ruskin JN, Reid PR.
    Am J Cardiol; 1985 Apr 01; 55(8):956-62. PubMed ID: 3984883
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.